Miller Brian W, Frost Sofia H L, Frayo Shani L, Kenoyer Aimee L, Santos Erlinda, Jones Jon C, Green Damian J, Hamlin Donald K, Wilbur D Scott, Fisher Darrell R, Orozco Johnnie J, Press Oliver W, Pagel John M, Sandmaier Brenda M
Pacific Northwest National Laboratory, Richland, Washington 99354 and College of Optical Sciences, The University of Arizona, Tucson, Arizona 85719.
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109.
Med Phys. 2015 Jul;42(7):4094-105. doi: 10.1118/1.4921997.
PURPOSE: Alpha-emitting radionuclides exhibit a potential advantage for cancer treatments because they release large amounts of ionizing energy over a few cell diameters (50-80 μm), causing localized, irreparable double-strand DNA breaks that lead to cell death. Radioimmunotherapy (RIT) approaches using monoclonal antibodies labeled with α emitters may thus inactivate targeted cells with minimal radiation damage to surrounding tissues. Tools are needed to visualize and quantify the radioactivity distribution and absorbed doses to targeted and nontargeted cells for accurate dosimetry of all treatment regimens utilizing α particles, including RIT and others (e.g., Ra-223), especially for organs and tumors with heterogeneous radionuclide distributions. The aim of this study was to evaluate and characterize a novel single-particle digital autoradiography imager, the ionizing-radiation quantum imaging detector (iQID) camera, for use in α-RIT experiments. METHODS: The iQID camera is a scintillator-based radiation detection system that images and identifies charged-particle and gamma-ray/x-ray emissions spatially and temporally on an event-by-event basis. It employs CCD-CMOS cameras and high-performance computing hardware for real-time imaging and activity quantification of tissue sections, approaching cellular resolutions. In this work, the authors evaluated its characteristics for α-particle imaging, including measurements of intrinsic detector spatial resolutions and background count rates at various detector configurations and quantification of activity distributions. The technique was assessed for quantitative imaging of astatine-211 ((211)At) activity distributions in cryosections of murine and canine tissue samples. RESULTS: The highest spatial resolution was measured at ∼20 μm full width at half maximum and the α-particle background was measured at a rate as low as (2.6 ± 0.5) × 10(-4) cpm/cm(2) (40 mm diameter detector area). Simultaneous imaging of multiple tissue sections was performed using a large-area iQID configuration (ø 11.5 cm). Estimation of the (211)At activity distribution was demonstrated at mBq/μg-levels. CONCLUSIONS: Single-particle digital autoradiography of α emitters has advantages over traditional film-based autoradiographic techniques that use phosphor screens, in terms of spatial resolution, sensitivity, and activity quantification capability. The system features and characterization results presented in this study show that the iQID is a promising technology for microdosimetry, because it provides necessary information for interpreting alpha-RIT outcomes and for predicting the therapeutic efficacy of cell-targeted approaches using α emitters.
目的:发射α粒子的放射性核素在癌症治疗中具有潜在优势,因为它们在几个细胞直径(50 - 80μm)的范围内释放大量电离能量,导致局部、不可修复的双链DNA断裂,从而导致细胞死亡。因此,使用标记有α发射体的单克隆抗体的放射免疫疗法(RIT)方法可以使靶向细胞失活,同时对周围组织造成最小的辐射损伤。需要工具来可视化和量化放射性分布以及靶向和非靶向细胞的吸收剂量,以便对所有利用α粒子的治疗方案(包括RIT和其他方案(如Ra - 223))进行准确的剂量测定,特别是对于放射性核素分布不均匀的器官和肿瘤。本研究的目的是评估和表征一种新型单粒子数字放射自显影成像仪,即电离辐射量子成像探测器(iQID)相机,用于α - RIT实验。 方法:iQID相机是一种基于闪烁体的辐射检测系统,它能在逐个事件的基础上对带电粒子和γ射线/ X射线发射进行空间和时间上的成像和识别。它采用CCD - CMOS相机和高性能计算硬件对组织切片进行实时成像和活性定量,接近细胞分辨率。在这项工作中,作者评估了其α粒子成像特性,包括在各种探测器配置下测量探测器的固有空间分辨率和背景计数率,以及对活性分布进行定量。该技术用于对小鼠和犬类组织样本冷冻切片中砹 - 211((211)At)活性分布进行定量成像评估。 结果:测量得到的最高空间分辨率约为半高宽20μm,α粒子背景计数率低至(2.6 ± 0.5) × 10(-4) cpm/cm(2)(探测器面积为40mm直径)。使用大面积iQID配置(ø 11.5 cm)对多个组织切片进行了同时成像。在mBq/μg水平上展示了对(211)At活性分布的估计。 结论:与使用磷光屏的传统基于胶片的放射自显影技术相比,α发射体的单粒子数字放射自显影在空间分辨率、灵敏度和活性定量能力方面具有优势。本研究中呈现的系统特性和表征结果表明,iQID是一种有前途的微剂量测定技术,因为它为解释α - RIT结果以及预测使用α发射体进行细胞靶向方法的治疗效果提供了必要信息。
Nucl Instrum Methods Phys Res A. 2014-12-11
Curr Radiopharm. 2011-7
Commun Eng. 2025-5-15
Brachytherapy. 2023
Proc SPIE Int Soc Opt Eng. 2012-8-12
Nucl Instrum Methods Phys Res A. 2014-12-11
Curr Hematol Malig Rep. 2012-3
Proc SPIE Int Soc Opt Eng. 2009
IEEE Nucl Sci Symp Conf Rec (1997). 2009-11-1
IEEE Trans Nucl Sci. 2009-6-1